baricitinib

Digital X-ray brain on blue background neurons

Research

AI tags Lilly's RA drug Olumiant as potential Alzheimer's remedy

Using machine learning, researchers at Harvard and Mass General identified JAK inhibitors as promising candidates to treat Alzheimer's.

Arlene Weintraub Mar 8, 2021 8:55am

lillyhq

FDA ‘conflicted’ on Lilly and Incyte’s refiled baricitinib

Apr 20, 2018 5:13am

fda

Critical FDA director jumps to AstraZeneca

Apr 19, 2018 5:00pm

Palm close-up

Lilly/Incyte's baricitinib musters mixed data in eczema

Sep 15, 2017 10:07am

Eli Lilly headquarters

Lilly, Incyte reveal earlier-than-expected baricitinib refiling

Aug 30, 2017 10:05am

FDA

Lilly, Incyte hit with FDA rejection, need for more data on baricitinib

Apr 14, 2017 9:54am